{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:42:51Z","timestamp":1761561771811},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ther Innov Regul Sci"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1177\/2168479013492736","type":"journal-article","created":{"date-parts":[[2013,6,12]],"date-time":"2013-06-12T01:16:08Z","timestamp":1370999768000},"page":"489-494","update-policy":"http:\/\/dx.doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Pharmacotherapeutic Follow-up and Pharmacogenetics of CYP2C9 and CYP3A4 in Antihypertensive Therapy: A Pilot Study in a Community Pharmacy"],"prefix":"10.1007","volume":"47","author":[{"given":"Mar\u00eda Jes\u00fas","family":"Rodr\u00edguez-Arcas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Garc\u00eda-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurora","family":"Montesinos-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Mart\u00ednez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Conesa-Zamora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,30]]},"reference":[{"key":"47040489_CR1","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.amjmed.2007.02.003","volume":"120","author":"BJ Materson","year":"2007","unstructured":"Materson BJ. Variability in response to antihypertensive drugs. Am J Med. 2007;120:S10\u2013S20.","journal-title":"Am J Med"},{"key":"47040489_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2217\/17410541.5.1.37","volume":"5","author":"L Chialda","year":"2008","unstructured":"Chialda L, Griffith LS. Prospective use of CYP pharmacogenetics and medication analysis to facilitate improved therapy: a pilot study. Per Med. 2008;5:37\u201345.","journal-title":"Per Med"},{"key":"47040489_CR3","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1097\/00008571-200412000-00004","volume":"14","author":"BP King","year":"2004","unstructured":"King BP, Khan TI, Aithal GP, Kamali F, Daly AK. Upstream and coding region CYP2C9 polymorphisms: correlation with warfarin dose and metabolism. Pharmacogenetics. 2004;14:813\u2013822.","journal-title":"Pharmacogenetics"},{"key":"47040489_CR4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.bbrc.2005.09.020","volume":"338","author":"C Rodr\u00edguez-Antona","year":"2005","unstructured":"Rodr\u00edguez-Antona C, Sayi JG, Gustafsson LL, Bertilsson L, Ingelman-Sundberg M. Phenotype-genotype variability in the human CYP3A locus as assessed by the probe drug quinine and analyses of variant CYP3A4 alleles. Biochem Biophys Res Commun. 2005;338:299\u2013305.","journal-title":"Biochem Biophys Res Commun"},{"key":"47040489_CR5","doi-asserted-by":"publisher","first-page":"738","DOI":"10.2174\/138920008786049302","volume":"9","author":"SF Zhou","year":"2008","unstructured":"Zhou SF, Di YM, Chan E, et al. Clinical pharmacogenetics and potential application in personalized medicine. Curr Drug Metab. 2008;9:738\u2013784.","journal-title":"Curr Drug Metab"},{"key":"47040489_CR6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.farma.2010.05.006","volume":"35","author":"MJ Rodr\u00edguez Arcas","year":"2011","unstructured":"Rodr\u00edguez Arcas MJ, Garc\u00eda-Jim\u00e9nez E, Mart\u00ednez-Mart\u00ednez F, Conesa-Zamora P. Role of CYP450 in pharmacokinetics and pharmacogenetics of antihypertensive drugs. Farm Hosp. 2011;35:84\u201392.","journal-title":"Farm Hosp"},{"key":"47040489_CR7","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2217\/17410541.4.4.393","volume":"4","author":"JB Marteau","year":"2007","unstructured":"Marteau JB, Gambier N, Jeannesson E, Siest G, Visvikis-Siest S. Pharmacogenomics and antihypertensive drugs: a path toward personalized medicine. Per Med. 2007;4:393\u2013412.","journal-title":"Per Med"},{"key":"47040489_CR8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.18553\/jmcp.2012.18.4.311","volume":"18","author":"P Amariles","year":"2012","unstructured":"Amariles P, Sabater-Hern\u00e1ndez D, Garc\u00eda-Jim\u00e9nez E, et al. Effectiveness of Dader method for pharmaceutical care on control of blood pressure and total cholesterol in outpatients with cardiovascular disease or cardiovascular risk: EMDADER-CV randomized controlled trial. J Manag Care Pharm. 2012;18:311\u2013323.","journal-title":"J Manag Care Pharm"},{"issue":"1","key":"47040489_CR9","first-page":"44","volume":"4","author":"Pharmaceutical Care Research Group, University of Granada Spain.","year":"2006","unstructured":"Pharmaceutical Care Research Group, University of Granada (Spain). Pharmacotherapy follow-up: the Dader method [in Spanish]. 3rd rev. Pharmacy Practice. 2006; 4(1):44\u201353. Available at: http:\/\/scielo.isciii.es\/pdf\/pharmacy\/v4n1\/giaf.pdf. Accessed April 9, 2012.","journal-title":"Pharmacy Practice"},{"issue":"1","key":"47040489_CR10","first-page":"5","volume":"48","author":"Committee of Consensus.","year":"2007","unstructured":"Committee of Consensus. Third consensus of Granada on drug-related problems (DRP) and negative outcomes associated with medication (NOM). Ars Pharm. 2007;48(1):5\u201317. Available at: http:\/\/farmacia.ugr.es\/ars\/ars_web\/ProjectARS\/pdf\/374.pdf. Accessed April 9, 2012.","journal-title":"Ars Pharm"},{"key":"47040489_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","volume":"24","author":"DE Morisky","year":"1986","unstructured":"Morisky DE, Green LW, Levine AM. Concurrent and predictor validity of a self-reported measure of medication adherence. Med Care. 1986;24:67\u201374.","journal-title":"Med Care"},{"key":"47040489_CR12","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","volume":"24","author":"RM Conroy","year":"2003","unstructured":"Conroy RM, Py\u00f6r\u00e4l\u00e4 K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987\u20131003.","journal-title":"Eur Heart J"},{"key":"47040489_CR13","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1097\/HJH.0b013e328333146d","volume":"27","author":"G Mancia","year":"2009","unstructured":"Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hyperten. 2009;27:2121\u20132158.","journal-title":"J Hyperten"},{"key":"47040489_CR14","doi-asserted-by":"publisher","first-page":"703","DOI":"10.2217\/14622416.8.7.703","volume":"8","author":"E Oliveira","year":"2007","unstructured":"Oliveira E, Marsh S, van Booven DJ, Amorim A, Prata MJ, McLeod HL. Pharmacogenetically relevant polymorphism in Portugal. Pharmacogenomics. 2007;8:703\u2013712.","journal-title":"Pharmacogenomics"},{"key":"47040489_CR15","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1111\/j.1440-1681.2007.04665.x","volume":"34","author":"A Crecenti","year":"2007","unstructured":"Crecenti A, Mas S, Gass\u00f3 P, Baiget M, Bernardo M, Lafuente A. Simultaneous genotyping of CYP2D6 *3, *4, *5 y *6 polymorphisms in a Spanish population through multiplex long polymerase chain reaction and minisequencing multiplex single base extension analysis. Clin Exp Pharmacol Physiol. 2007;34:992\u2013997.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"47040489_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1331\/JAPhA.2011.10178","volume":"51","author":"L Padgett","year":"2011","unstructured":"Padgett L, O\u2019Connor S, Roederer M, McLeod H, Ferreri S. Pharmacogenomics in a community pharmacy: ACT now. J Am Pharm Assoc (2003). 2011;51:189\u2013193.","journal-title":"J Am Pharm Assoc (2003)"},{"key":"47040489_CR17","first-page":"44c","volume":"2","author":"EJ Topol","year":"2010","unstructured":"Topol EJ. Pharmacy benefit managers, pharmacies, and pharmacogenomic testing: prescription for progress? Sci Transl Med. 2010;2:44cm22.","journal-title":"Sci Transl Med"},{"key":"47040489_CR18","doi-asserted-by":"publisher","first-page":"955","DOI":"10.2217\/pgs.12.67","volume":"13","author":"SK O\u2019Connor","year":"2012","unstructured":"O\u2019Connor SK, Ferreri SP, Michaels NM, et al. Exploratory planning and implementation of a pilot pharmacogenetic program in a community pharmacy. Pharmacogenomics. 2012;13:955\u2013962.","journal-title":"Pharmacogenomics"},{"key":"47040489_CR19","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s11096-008-9264-x","volume":"31","author":"DB Wieren-de Wijer van","year":"2009","unstructured":"van Wieren-de Wijer DB, Maitland-van der Zee AH, de Boer A, et al. Recruitment of participants through community pharmacies for a pharmacogenetic study of antihypertensive drug treatment. Pharm World Sci. 2009;31:158\u2013164.","journal-title":"Pharm World Sci"},{"key":"47040489_CR20","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1157\/13074389","volume":"124","author":"MJ Medrano","year":"2005","unstructured":"Medrano MJ, Cerrato E, Boix R, Delgado-Rodr\u0155guez M. Cardiovascular risk factors in Spanish population: metaanalysis of cross-sectional studies. Med Clin (Barc). 2005;124:606\u2013612.","journal-title":"Med Clin (Barc)"},{"key":"47040489_CR21","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1177\/0897190009336668","volume":"23","author":"BL Armor","year":"2010","unstructured":"Armor BL, Britton ML, Dennis VC, Letassy NA. A review of pharmacist contributions to diabetes care in the United States. J Pharm Pract. 2010;23:250\u2013264.","journal-title":"J Pharm Pract"},{"key":"47040489_CR22","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1345\/aph.1L289","volume":"44","author":"JD Robinson","year":"2010","unstructured":"Robinson JD, Segal R, Lopez LM, Doty RE. Impact of a pharmaceutical care intervention on blood pressure control in a chain pharmacy practice. Ann Pharmacother. 2010;44:88\u201396.","journal-title":"Ann Pharmacother"}],"container-title":["Therapeutic Innovation & Regulatory Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1177\/2168479013492736.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2168479013492736","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1177\/2168479013492736\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2168479013492736","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1177\/2168479013492736.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T22:21:57Z","timestamp":1645741317000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1177\/2168479013492736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["47040489"],"URL":"https:\/\/doi.org\/10.1177\/2168479013492736","relation":{},"ISSN":["2168-4790","2168-4804"],"issn-type":[{"value":"2168-4790","type":"print"},{"value":"2168-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}